Selecting a high-grade MOTS-C supplier requires careful examination of analytical documentation, synthesis standards, and lot-to-lot consistency. As a novel mitochondrial-derived peptide under active investigation for cellular energy signaling and metabolic regulation, laboratory researchers must demand rigorous quality controls before procuring material. This comprehensive guide outlines the key criteria for evaluating suppliers to ensure valid, reproducible preclinical data.
Selecting a high-grade MOTS-C supplier requires careful examination of analytical documentation, synthesis standards, and lot-to-lot consistency. As a novel mitochondrial-derived peptide under active investigation for cellular energy signaling and metabolic regulation, laboratory researchers must demand rigorous quality controls before procuring material. This comprehensive guide outlines the key criteria for evaluating suppliers to ensure valid, reproducible preclinical data.
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) represents a distinct class of signaling molecules encoded within the mitochondrial genome. Unlike nuclear-encoded peptides, mitochondrial-derived peptides (MDPs) act as retrotransmitters, relaying metabolic status from the organelle to the nucleus. In vitro assays and animal models demonstrate that MOTS-C targets metabolic pathways, specifically activating AMP-activated protein kinase (AMPK) to regulate glucose homeostasis and lipid oxidation under metabolic stress.
Preclinical studies suggest that MOTS-C plays a pivotal role in metabolic regulation, exercise-capacity research, and cellular stress adaptation. Investigators examining metabolic flexibility, insulin sensitivity pathways, and age-related decline utilize MOTS-C research peptide to map nuclear-mitochondrial cross-talk. Given the sensitivity of mitochondrial signaling cascades in vitro, obtaining high-purity material free from salt contaminants or synthetic byproducts is critical for generating reliable experimental results.
When choosing a mots-c supplier, the primary indicator of reliability is the provision of a lot-specific Certificate of Analysis (COA) issued by an independent, ISO 17025 accredited laboratory. A compliant COA must detail analysis performed on the specific batch being purchased, rather than relying on historical or representative test data.
Researchers should scrutinize two essential analytical methodologies on every COA: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Reversed-Phase HPLC (RP-HPLC) determines chemical purity by separating the primary peptide sequence from truncated fragments, deletion sequences, and side-reaction byproducts. MS, typically via Electrospray Ionization (ESI-MS) or MALDI-TOF, confirms the exact molecular weight of the 16-amino acid sequence (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg), verifying structural identity down to the Dalton.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant risk to cell culture and animal models. In mitochondrial research, trace endotoxin contamination can trigger inflammatory signaling (such as NF-κB activation) that masks or alters the cellular response attributed to the peptide itself.
A qualified vendor must perform Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing on every production lot. For in vitro and preclinical research applications, endotoxin levels should fall well below standard laboratory safety limits (ideally <0.1 EU/mg). Reviewing a dedicated guide on endotoxin testing in research peptides helps procurement officers establish strict bioburden criteria for incoming laboratory reagents.
The synthesis pathway significantly influences peptide integrity and purity profile. Peptide synthesis performed in USA-based, GMP-compliant facilities adheres to rigid quality management systems (QMS), standardized raw material testing, and strict environmental controls. In contrast, overseas brokers often aggregate crude peptides synthesized without adequate purification steps, leading to variable net peptide content and batch-to-batch inconsistency.
Domestic manufacturing ensures traceable chain-of-custody and adherence to precise Solid-Phase Peptide Synthesis (SPPS) protocols. By choosing a domestic supplier that handles synthesis and packaging within ISO-certified environments, laboratories avoid common issues associated with imported compounds, such as residual trifluoroacetic acid (TFA) salts, heavy metal contaminants, or micro-heterogeneity.
Proper post-synthesis processing determines the long-term stability of MOTS-C. Following purification, the peptide must undergo lyophilization (freeze-drying) under controlled temperature and vacuum conditions to produce a uniform, moisture-free cake. High residual moisture accelerates peptide degradation via hydrolysis or oxidation during storage.
Suppliers must package lyophilized vials under inert gas (such as argon or nitrogen) in temperature-monitored facilities. For cold-chain logistics, same-day shipping protocols from temperature-controlled distribution hubs (such as California and Arizona) minimize exposure to thermal spikes during transport. Investigators should review standard peptide storage protocols to preserve peptide integrity upon receipt in the laboratory.
When designing mitochondrial signaling protocols, researchers frequently compare MOTS-C against other mitochondrial-targeted compounds. While MOTS-C primary mechanism targets nuclear gene expression and systemic metabolic control via AMPK signaling, other peptides act through distinct structural or antioxidant pathways within the inner mitochondrial membrane.
For example, Humanin is another prominent mitochondrial-derived peptide studied for cytoprotective and anti-apoptotic signaling, whereas SS-31 (Elamipretide) specifically targets cardiolipin within the inner mitochondrial membrane to restore electron transport chain efficiency. Researchers building comprehensive cellular energy studies can explore the broader mitochondrial-derived peptides catalog to select the appropriate control or co-treatment compounds for their specific experimental designs.
To streamline vendor selection, lab directors and purchasing departments can utilize a standardized evaluation checklist before issuing purchase orders:
1. **Analytical Transparency:** Does the supplier provide lot-specific HPLC and MS reports from an independent ISO 17025 laboratory? 2. **Synthesis Source:** Is the compound synthesized in the USA under GMP-compliant facility standards? 3. **Bioburden Documentation:** Is there clear verification of endotoxin levels below 0.1 EU/mg? 4. **Counterparty Policies:** Does the vendor maintain clear replacement or refund policies for lots failing quality verification? 5. **Fulfillment Logistics:** Are compounds shipped promptly from domestic facilities with thermal protections? By ensuring a prospective supplier checks every item on this list, facilities protect their budgets and scientific repeatability.
PX1 Research serves academic institutions, biotechnology organizations, and contract research organizations (CROs) by supplying strictly verified research compounds for in vitro and preclinical applications. Every batch of MOTS-C offered by PX1 Research undergoes rigorous identity, purity, and bioburden testing prior to release.
PX1 provides complete analytical transparency across its PX1 research catalog. Institutional clients requiring bulk quantities or custom synthesis lots can access dedicated support through bulk lab accounts to obtain high-volume pricing, custom packaging, and comprehensive batch documentation tailored for multi-phase laboratory projects.
What is the primary role of MOTS-C in preclinical research?
MOTS-C is a mitochondrial-derived peptide investigated for its role in metabolic regulation, exercise-capacity research, cellular stress response, and nuclear-mitochondrial communication via AMPK activation.
How do I verify the purity of MOTS-C from a supplier?
Review the lot-specific Certificate of Analysis (COA). Look for Reversed-Phase HPLC results confirming high chemical purity (typically >98%) and Mass Spectrometry (ESI-MS or MALDI-TOF) data matching the expected molecular weight.
Why is endotoxin testing critical for MOTS-C research peptides?
Endotoxins can induce inflammatory signaling pathways in cellular assays and animal models, confounding experimental results. A reputable supplier conducts LAL or rFC testing to confirm endotoxin levels are below rigorous thresholds.
Is MOTS-C supplied by PX1 Research synthesized in the USA?
Yes, PX1 Research provides USA-synthesized compounds produced in GMP-compliant facilities with full analytical traceability and ISO 17025 lab verification.
How should lyophilized MOTS-C be stored upon arrival?
Lyophilized MOTS-C should be stored in a freezer at -20°C or -80°C away from light and moisture. After reconstitution in a sterile laboratory buffer, aliquot and store cold to prevent freeze-thaw degradation.
Can PX1 Research provide bulk orders for institutional laboratories?
Yes, PX1 Research offers institutional supply options, custom lot reservation, and bulk pricing arrangements for qualified research organizations through dedicated wholesale accounts.
How does MOTS-C differ from SS-31 or Humanin?
While MOTS-C acts primarily as a retrotransmitting peptide regulating nuclear gene expression and metabolic homeostasis, Humanin focuses on cytoprotective cascades, and SS-31 targets inner mitochondrial cardiolipin directly.
Are PX1 Research compounds intended for clinical or human use?
No. All products supplied by PX1 Research are strictly for laboratory research, in vitro assays, and preclinical animal studies. They are not for human consumption, therapeutic, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.